UNITED KINGDOM / AGILITYPR.NEWS / June 26, 2025 / The growing interest in GLP-1 medications for weight loss could be creating a new generational gender divide, one top provider has warned with men notably underrepresented says Well by Vertis. The health tech startup founded by Vertis Health says it is vital that greater gender equality is prioritised in obesity support services.

Despite obesity affecting 67% of men in the UK - more than women - research shows that men account for only 10-30% of participants in weight management programmes. The imbalance isn’t due to lack of need, but likely due to lack of access and engagement. Well by Vertis is tackling this concerning trend head-on by offering personalised, confidential, and male-focused care that meets men where they are.

“Equality in access is public health imperative, but men often feel invisible in the weight management conversation,” said Stephanie Smith, Lead Nurse at Well by Vertis.

“We ensure their experience is different - rooted in empathy but grounded in practicality. Our one-to-one model is built on trust, not gym ‘tough love’. We give them what they need: clear data, targeted advice, and an environment where they feel understood.”

Cultural expectations, discomfort with group-based services, and traditional gender norms all contribute to why men are less likely to seek weight loss support. Many services are designed with women in mind, inadvertently alienating male clients. But when men do receive support, they often respond well by engaging consistently and achieving comparable, if not better, outcomes than their female counterparts.

Well by Vertis provides:

• Private, one-to-one consultations with expert clinicians
• Emotionally safe spaces for discussing weight, health goals and medication use
• Practical, personalised advice that aligns with men’s routines and preferences
• Ongoing, non-judgemental support to track progress and build sustainable habits

By offering a confidential and data-driven approach tailored to individual lifestyles, Well by Vertis helps men feel empowered rather than excluded.

As the use of GLP-1 medications such as Wegovy and Mounjaro becomes more common, Well by Vertis ensures that men have equal access to medical weight loss solutions under appropriate clinical supervision. These medications are never a “quick fix” and must be accompanied by professional support to ensure both safety and success.

For more information, visit https://www.wearewell.org.uk